Editorial: Safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor‐induced colitis
Alimentary Pharmacology & Therapeutics
by Stephen Hanauer, Yinghong Wang, Malek Shatila
2d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Letter: elderly AS‐AIH patients need more attention
Alimentary Pharmacology & Therapeutics
by Mengyi Shen, Xiaoli Fan, Yi Shen, Li Yang
2d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Editorial: P‐CABs for treatment of reflux oesophagitis—Is this the future?
Alimentary Pharmacology & Therapeutics
by Sydney Pomenti, David A. Katzka
2d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Editorial: Safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor‐induced colitis—authors' reply
Alimentary Pharmacology & Therapeutics
by Emilie K. Dahl, Osama K. Abed, Jens Kjeldsen, Marco Donia, Inge M. Svane, Anders Dige, Jørgen S. Agnholt, Jacob T. Bjerrum, Jakob B. Seidelin
2d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Editorial: Ustekinumab during pregnancy—reassuring but still not enough. Authors' reply
Alimentary Pharmacology & Therapeutics
by Ariella Bar‐Gil Shitrit, Irit Avni‐biron
2d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Editorial: chronic hepatitis C with metabolic dysfunction‐associated fatty liver disease — A model for adoption of Sustainable Development Goal 3
Alimentary Pharmacology & Therapeutics
by Oyekoya Ayonrinde, Richard Goodheart
2d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Editorial: The impact of COVID on the management of IBD flares: Different care but similar outcomes—Authors' reply
Alimentary Pharmacology & Therapeutics
by Aamir Saifuddin, Alexandra J. Kent, Shameer J. Mehta, Shaji Sebastian
2d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Systematic review: the role of frailty in advanced chronic liver disease
Alimentary Pharmacology & Therapeutics
by Sarah P. Bowers, Paul N. Brennan, John F. Dillon
1w ago
The role of frailty indices in advanced chronic liver disease. Summary Background Frailty is a known predictor of outcome and mortality in patients undergoing liver transplantation. However, most patients remain unsuitable transplant candidates. It is not yet known if the assessment of frailty in non-transplant candidates can aid prognostication. Aim To collate and interrogate the various frailty tools presently used to predict mortality in the non-transplant cirrhosis setting. Methods A comprehensive review of MEDLINE and EMBASE databases for articles published from inception to March 2022 ..read more
Visit website
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg‐positive chronic hepatitis B
Alimentary Pharmacology & Therapeutics
by Josef Wagner, Lilly Yuen, Margaret Littlejohn, Vitina Sozzi, Kathy Jackson, Ross Martin, Thomas Aeschbacher, Vithika Suri, Susanna K. Tan, Becket Feierbach, Anuj Gaggar, Patrick Marcellin, Maria Buti Ferret, Harry L. A. Janssen, Ed Gane, Niamh Meagher, David J. Price, Darren Wong, Alexander T. Thompson, Peter A. Revill
1w ago
Hepatitis B virus (HBV) haplotype number ≤2 predicts HBV genotype A and D patients who will, or will not achieve HBsAg loss on direct acting antiviral therapy Summary Backgrounds and Aims We investigated associations between hepatitis B virus (HBV) genome-length haplotype number (HN) at baseline in subjects with HBeAg-positive chronic hepatitis B (CHB), and the likelihood of achieving functional cure during direct-acting antiviral therapy Method We analysed 86 HBeAg-positive baseline samples from patients with HBV genotypes A and D who were enrolled in a Phase II trial of tenofovir disoproxi ..read more
Visit website
Systematic review: early feeding practices and the risk of coeliac disease. A 2022 update and revision
Alimentary Pharmacology & Therapeutics
by Hania Szajewska, Raanan Shamir, Agata Stróżyk, Anna Chmielewska, Bartłomiej M. Zalewski, Renata Auricchio, Sibylle Koletzko, Ilma R. Korponay‐Szabo, M. Luisa Mearin, Caroline Meijer, Carmen Ribes‐Koninckx, Riccardo Troncone, the PreventCD project group
2w ago
For the population at genetic risk of developing coeliac disease (CD), breastfeeding and age at gluten introduction haveno effect on the cumulative incidence of CD during childhood. There is some evidence for an effect of the amount of gluten consumed at weaning and/or thereafter on CD/CD-related autoimmunity risk. Summary Background The effects of early feeding practices on the risk of coeliac disease (CD) remain debated. Aims To update evidence on these practices on the risk of CD and/or CD-related autoimmunity (CDA), defined as anti-transglutaminase or anti-endomysial antibody positivity ..read more
Visit website

Follow Alimentary Pharmacology & Therapeutics on Feedspot

Continue with Google
OR